Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol Plus PPI vs PPI Alone for Peptic Ulcer in Cirrhosis
NCT04140591Phase 3Terminated
- Sponsor
- Taipei Veterans General Hospital
- Start
- Dec 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propranolol in peptic ulcer disease (PUD), sponsored by Taipei Veterans General Hospital. Started Dec 2016; status: terminated.
02
Drugs
propranolol
03
Conditions
peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT04140591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140591.